Regencell Bioscience Holdings Limited Operating Cash Flow
Regencell Bioscience Holdings Limited (RGC) reported Operating Cash Flow of -$3.11 million for the 12-month period ending 2025-06-30, per its 20-F filed 2025-10-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2025-10-31
| Period end | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|
| 2025-06-30 | -$3.11M 20-F · filed 2025-10-31 |
| 2024-06-30 | -$4.00M 20-F · filed 2025-10-31 |
| 2023-06-30 | -$4.96M 20-F · filed 2025-10-31 |
| 2022-06-30 | -$5.27M 20-F · filed 2024-10-25 |
| 2021-06-30 | -$767.31K 20-F · filed 2023-10-27 |
| 2020-06-30 | -$726.57K 20-F · filed 2022-10-31 |
| 2019-06-30 | -$390.99K 20-F · filed 2021-10-29 |